StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca cash

Cash and short-term investments held at the end of each period.

AstraZeneca's cash was $4.89B at Jun 30, 2026. For fiscal 2025 it was $5.71B, up 4.1% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is $7.83B in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.71B+4.1%
FY2024Dec 31, 2024$5.49B-6.0%
FY2023Dec 31, 2023$5.84B-5.3%
FY2022Dec 31, 2022$6.17B-2.6%
FY2021Dec 31, 2021$6.33B-19.2%
FY2020Dec 31, 2020$7.83B+45.9%
FY2019Dec 31, 2019$5.37B+11.1%
FY2018Dec 31, 2018$4.83B+45.3%
FY2017Dec 31, 2017$3.32B-33.8%
FY2016Dec 31, 2016$5.02B-19.6%
FY2015Dec 31, 2015$6.24B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.89B-29.3%
Q4 FY2025Dec 31, 2025$5.71B-2.2%
Q2 FY2025Jun 30, 2025$7.06B+24.6%
Q4 FY2024Dec 31, 2024$5.49B-11.0%
Q2 FY2024Jun 30, 2024$6.92B+43.6%
Q4 FY2023Dec 31, 2023$5.84B-7.7%
Q2 FY2023Jun 30, 2023$5.66B-63.6%
Q4 FY2022Dec 31, 2022$6.17B-21.3%
Q2 FY2022Jun 30, 2022$4.82B-15.1%
Q4 FY2021Dec 31, 2021$6.33B+17.9%
Q2 FY2021Jun 30, 2021$15.57B+186.8%
Q4 FY2020Dec 31, 2020$7.83B+62.1%
Q2 FY2020Jun 30, 2020$5.67B+90.5%
Q4 FY2019Dec 31, 2019$5.37B+61.5%
Q2 FY2019Jun 30, 2019$5.43B+3.6%
Q4 FY2018Dec 31, 2018$4.83B-3.7%
Q2 FY2018Jun 30, 2018$2.98B-52.3%
Q4 FY2017Dec 31, 2017$3.32B–
Q2 FY2017Jun 30, 2017$5.24B–
Q4 FY2016Dec 31, 2016$5.02B–
Q4 FY2015Dec 31, 2015$6.24B–

More AstraZeneca figures

See a number that looks wrong?